(3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-7-(1,1-difluoroethyl)-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide
C37H29ClF8N8O4S — CID 156662118
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-7-(1,1-difluoroethyl)-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide
(3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-7-(1,1-difluoroethyl)-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide (PubChem CID 156662118) has the molecular formula C37H29ClF8N8O4S and a molecular weight of 869.19 g/mol. Its IUPAC name is (3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-7-(1,1-difluoroethyl)-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide.
Molecular Properties
| Compound Name | (3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-7-(1,1-difluoroethyl)-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide |
|---|---|
| PubChem CID | 156662118 |
| Molecular Formula | C37H29ClF8N8O4S |
| Molecular Weight | 869.19 g/mol |
| Exact Mass | 868.16 |
| IUPAC Name | (3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-7-(1,1-difluoroethyl)-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide |
| SMILES | Cn1nc(NS(C)(=O)=O)c2c(Cl)ccc(-n3c([C@@H](Cc4cc(F)cc(F)c4)C(C(N)=O)n4nc(C(F)F)c5c4C(F)(F)[C@@H]4C[C@H]54)nc4cc(C(C)(F)F)ccc4c3=O)c21 |
| InChI | InChI=1S/C37H29ClF8N8O4S/c1-36(43,44)15-4-5-18-23(11-15)48-34(53(35(18)56)24-7-6-22(38)26-29(24)52(2)50-33(26)51-59(3,57)58)20(10-14-8-16(39)12-17(40)9-14)28(32(47)55)54-30-25(27(49-54)31(41)42)19-13-21(19)37(30,45)46/h4-9,11-12,19-21,28,31H,10,13H2,1-3H3,(H2,47,55)(H,50,51)/t19-,20-,21+,28?/m0/s1 |
| InChIKey | XVXZXOFWRCLLNF-MNTVDYPVSA-N |
| XLogP | 7.08 |
| TPSA | 159.79 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 869.19 |
| LogP ≤ 5 | 7.08 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156662118 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.